Stock 3390 TYCOON GROUP HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tycoon Group Holdings Limited

Equities

3390

KYG9143T1085

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 am EDT 		5-day change 1st Jan Change
4.04 HKD +0.25% Intraday chart for Tycoon Group Holdings Limited +0.25% -12.55%
Mar. 28 Tycoon Group Reports 581% Profit Surge For 2023; Declares Dividend MT
Mar. 27 Tycoon Group Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2023, Payable on July 12, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 1,312 1,072 1,720 3,696
Enterprise Value (EV) 1 1,391 1,239 1,987 3,863
P/E ratio -19.7 x -55.5 x 38.4 x 12.2 x
Yield - - 1.4% 1.52%
Capitalization / Revenue 2.59 x 1.21 x 1.45 x 3.08 x
EV / Revenue 2.75 x 1.39 x 1.68 x 3.22 x
EV / EBITDA -37.4 x 112 x 25.6 x 28 x
EV / FCF -24.9 x -26.1 x -24.8 x 54 x
FCF Yield -4.02% -3.83% -4.03% 1.85%
Price to Book 4.55 x 4.16 x 5.86 x 6.89 x
Nbr of stocks (in thousands) 800,000 800,000 800,000 800,000
Reference price 2 1.640 1.340 2.150 4.620
Announcement Date 4/22/21 4/21/22 4/13/23 4/12/24
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 693.3 700.8 506 888.9 1,186 1,199
EBITDA 1 137.7 90.51 -37.18 11.07 77.69 138.1
EBIT 1 135.5 86.37 -41.79 4.333 70.49 130.3
Operating Margin 19.54% 12.33% -8.26% 0.49% 5.94% 10.87%
Earnings before Tax (EBT) 1 123.7 68.36 -68.47 -17.5 50.37 317.7
Net income 1 100.9 54.52 -61.13 -18.82 43.75 297.3
Net margin 14.55% 7.78% -12.08% -2.12% 3.69% 24.8%
EPS - 1.379 -0.0834 -0.0241 0.0560 0.3800
Free Cash Flow 1 37.04 65.97 -55.95 -47.51 -80.05 71.47
FCF margin 5.34% 9.41% -11.06% -5.34% -6.75% 5.96%
FCF Conversion (EBITDA) 26.91% 72.89% - - - 51.75%
FCF Conversion (Net income) 36.71% 121.01% - - - 24.04%
Dividend per Share - - - - 0.0300 0.0700
Announcement Date 3/30/20 3/30/20 4/22/21 4/21/22 4/13/23 4/12/24
1HKD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 131 116 79 167 267 167
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.955 x 1.284 x -2.124 x 15.13 x 3.437 x 1.21 x
Free Cash Flow 1 37 66 -56 -47.5 -80.1 71.5
ROE (net income / shareholders' equity) 85.1% 46.9% -29.8% -6.31% 15.7% 71.1%
ROA (Net income/ Total Assets) 27.3% 14.5% -5.3% 0.36% 4.65% 8.14%
Assets 1 370.1 376.1 1,154 -5,217 940.2 3,652
Book Value Per Share - 2.990 0.3600 0.3200 0.3700 0.6700
Cash Flow per Share - 1.280 0.1500 0.0900 0.0900 0.0500
Capex 1 34.2 5.23 11.4 7.91 1.46 3.88
Capex / Sales 4.93% 0.75% 2.26% 0.89% 0.12% 0.32%
Announcement Date 3/30/20 3/30/20 4/22/21 4/21/22 4/13/23 4/12/24
1HKD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
TYCOON GROUP HOLDINGS LIMITED Stock Tycoon Group Holdings Limited
-12.55% 412M
MCKESSON CORPORATION Stock McKesson Corporation
+16.01% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+1.97% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-1.22% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.95% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.48% 7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+15.26% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 3.93B
GALENICA AG Stock Galenica AG
-3.02% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.10% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 3390 Stock
  4. Financials Tycoon Group Holdings Limited